Clinical Research/R&D

  • Your Selections:

Refine Results



South Africa Launches HIV/AIDS Vaccine Trial

“The first clinical trial of an HIV/AIDS vaccine designed and developed in South Africa was launched in Cape Town” Monday, the SAPA/The Times reports.

WHO, Wyeth Launch Trial In Africa To Test New River Blindness Drug

The WHO on Wednesday announced plans for a clinical trial to test a new drug that “could halve the treatment period for river blindness [or onchocerciasis], a disease that threatens 100 million people mostly in Africa,” AFP/CNN Money reports.

Also In Global Health News: Children With HIV/AIDS; Leishmaniasis Treatment; ITNs In Tanzania; U.S. Malaria Fight; PEPFAR Safe Injection Funds

IRIN Examines Hardships Facing Parents, Guardians Of Children Living With HIV/AIDS IRIN examines the hardships parents and guardians of the estimated 170,000 Kenyan children currently infected with HIV often face. “Caregivers face the dilemma of how to disclose status to … [HIV-positive] children, and to whom,” as well as other…

Merck Partners With Non-Profit For Neglected Diseases Initiative

The pharmaceutical company, Merck, announced Monday it was partnering with the non-profit Drugs for Neglected Diseases initiative (DNDi) in an effort to improve treatments for neglected tropical diseases (NTD), the AP/CNBC reports.